Use of novel DNA methylation signatures to distinguish between human airway structural cell typesTools Rajasekar, P., Clifford, R.L., MacIsaac, J.L., McEwen, L.M., Kobor, M. and Knox, A.J. (2017) Use of novel DNA methylation signatures to distinguish between human airway structural cell types. In: American Thoracic Society 2017 International Conference, 19-24 May 2017, Washington, D.C., USA. Full text not available from this repository.
Official URL: http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A7227
AbstractINTRODUCTION: Chronic inflammatory and fibrotic lung diseases like asthma, COPD and pulmonary fibrosis are characterised by modified phenotype of the airway structural cells. Airway walls are comprised of a robust epithelial layer that lines the lumen followed by the basement membrane, submucosa predominantly composed of fibroblasts and finally enveloped by a bulk of smooth muscle cells that determine the relaxation and constriction of the airways. The phenotype of airway structural cells is determined by epigenetic alterations such as DNA methylation, which alters the activation status of a range of important inflammatory and remodelling genes. Here we determined if airway structural cells (Epithelial cells, fibroblasts and smooth muscle cells) have different DNA methylome signatures that can be used to distinguish between them. This will offer a reference standard for identifying cell type specific DNA methylation changes induced by various inflammatory stimuli.
Actions (Archive Staff Only)
|